methyl methanesulfonate has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goellner, EM | 1 |
| Grimme, B | 1 |
| Brown, AR | 1 |
| Lin, YC | 1 |
| Wang, XH | 1 |
| Sugrue, KF | 1 |
| Mitchell, L | 1 |
| Trivedi, RN | 1 |
| Tang, JB | 1 |
| Sobol, RW | 1 |
| Silber, JR | 1 |
| Bobola, MS | 1 |
| Blank, A | 1 |
| Schoeler, KD | 1 |
| Haroldson, PD | 1 |
| Huynh, MB | 1 |
| Kolstoe, DD | 1 |
2 other studies available for methyl methanesulfonate and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Overcoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repair.
Topics: Acrylamides; Adenosine Triphosphate; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Cell Survi | 2011 |
The apurinic/apyrimidinic endonuclease activity of Ape1/Ref-1 contributes to human glioma cell resistance to alkylating agents and is elevated by oxidative stress.
Topics: Antineoplastic Agents, Alkylating; Apurinic Acid; Brain Neoplasms; Carbon-Oxygen Lyases; Carmustine; | 2002 |